Hot Equities Reports: (OTCQB: TTNP), (OTCQB: AAMRQ)
Titan Pharmaceuticals Inc. (OTCQB: TTNP) stock is at $1.66, up 34.96 percent from its previous close of $1.23, up on the news of FDA advisors recommending approval of the company’s opioid dependence drug. However, its today’s volume of 3.625 million shares is higher than its usual trading volume of 921k shares. The stock opened the session at $1.90 which is also its highest price point for the session. Titan Pharmaceuticals’ lowest price point for the session stood at $1.50.
View full press release